According to the GuruFocus All-in-One Screener, the following stocks have high dividend yields but performed poorly over the past 12 months.
United Insurance Holdings Corp.’s (NASDAQ:UIHC) dividend yield is 1.43% with a payout ratio of 0.16%. Over the past 52 weeks, the price declined 10.9%. The stock is now trading with a price-earnings (P/E) ratio of 11.5 and a price-sales (P/S) ratio of 0.8.
The company has a market cap of $347.86 million. It is engaged in the property and casualty insurance business and operates in Florida, South Carolina and Massachusetts. The company also offers reinsurance services.
The profitability rating is 7 of 10. The return on equity (ROE) of 12.20% and return on assets (ROA) of 3.55% are outperforming the industry and are ranked higher than 69% of competitors. Financial strength has a rating of 7 of 10. Its cash-debt ratio of 5.55 is outperforming 55% of competitors.
Hot Performing Stocks To Invest In 2019: Karyopharm Therapeutics Inc.(KPTI)
Advisors’ Opinion:
- [By Chris Lange]
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) reported results from the Phase 2 portion of pivotal Phase 2/3 SEAL study of selinexor in dedifferentiated liposarcoma (DDLS). The previously reported results met PFS endpoint under RECIST criteria (5.5-month versus 2.7-month with placebo). No benefit was observed under World Health Organization (WHO) criteria, which in DDLS is considered to be a poorer determinant of tumor status since it can mistakenly classify stable disease as progressive disease. Wedbush expects the Phase 3 portion will succeed as well, but the firm notes the limited economic value in the indication given rarity and short duration of use.
- [By Cory Renauer]
Shares of Karyopharm Therapeutics (NASDAQ:KPTI), a precommercial biopharmaceutical company, are plummeting in response to briefing documents released by the Food and Drug Administration ahead of an advisory committee meeting. Investors expecting a rough road ahead have knocked the stock 46.7% lower as of 3:56 p.m. EST on Friday.
- [By Benzinga News Desk]
Shari Redstone is one “disloyal” media heiress, according to CBS (NYSE: CBS): Link
ECONOMIC DATA
US Initial Jobless Claims for May 18 234.0K vs 220.0K Est; Prior 222.0K. US Continuing Claims for May 11 1.74M vs 1.75M Est; Prior 1.71M
Existing home sales report for April will be released at 10:00 a.m. ET.
The Energy Information Administration’s weekly report on natural gas stocks in underground storage is schedule for release at 10:30 a.m. ET.
Atlanta Fed President Raphael Bostic will speak at 10:35 a.m. ET.
The Treasury is set to auction 7-year notes at 1:00 p.m. ET.
The Kansas City Fed manufacturing index for May will be released at 11:00 a.m. ET.
Philadelphia Federal Reserve Bank President Patrick Harker is set to speak at 2:00 p.m. ET.
Data on money supply for the latest week will be released at 4:30 p.m. ET.
ANALYST RATINGS
UBS upgrades Deere (NYSE: DE) from Neutral to Buy
Wells Fargo upgrades Oceaneering (NYSE: OII) from Market Perform to Outperform
Canaccord downgrades Vermillion (NASDAQ: VRML) from Buy to Hold
Wedbush downgrades Karyopharm Therapeutics (NASDAQ: KPTI) from Outperform to NeutralThis is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.
Hot Performing Stocks To Invest In 2019: Saul Centers, Inc.(BFS)
Advisors’ Opinion:
- [By Max Byerly]
Get a free copy of the Zacks research report on Saul Centers (BFS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Get a free copy of the Zacks research report on Saul Centers (BFS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Shares of Saul Centers, Inc. (NYSE:BFS) have been assigned a consensus recommendation of “Hold” from the seven analysts that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $54.50.
- [By Max Byerly]
Get a free copy of the Zacks research report on Saul Centers (BFS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Teachers Insurance & Annuity Association of America purchased a new position in shares of Saul Centers, Inc. (NYSE:BFS) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 13,437 shares of the real estate investment trust’s stock, valued at approximately $685,000. Teachers Insurance & Annuity Association of America owned approximately 0.06% of Saul Centers at the end of the most recent quarter.
Hot Performing Stocks To Invest In 2019: Lifeway Foods, Inc.(LWAY)
Advisors’ Opinion:
- [By Joseph Griffin]
Lifeway Foods, Inc. (NASDAQ:LWAY) COO Edward Smolyansky sold 4,890 shares of the company’s stock in a transaction that occurred on Monday, June 11th. The shares were sold at an average price of $6.41, for a total value of $31,344.90. Following the sale, the chief operating officer now owns 993,614 shares in the company, valued at approximately $6,369,065.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
- [By Logan Wallace]
Lifeway Foods (NASDAQ:LWAY) was downgraded by equities research analysts at TheStreet from a “c-” rating to a “d” rating in a report released on Friday.
Hot Performing Stocks To Invest In 2019: Pacific Biosciences of California Inc.(PACB)
Advisors’ Opinion:
- [By Cory Renauer]
Shares of Pacific Biosciences of California (NASDAQ:PACB), a genetic-sequencing system manufacturer, rose 11% on Thursday and continued their climb into Friday’s session. Investors appear pleased with new productivity-boosting tools to be featured at this week’s meeting of the American Society for Microbiology.
- [By Maxx Chatsko]
While the $1,000 benchmark has been well out of reach for other companies so far, Pacific Biosciences of California (NASDAQ:PACB) expects to join the coveted club in early 2019. Could this be the make or break moment investors have been waiting for?
- [By Shane Hupp]
News stories about Pacific Biosciences of California (NASDAQ:PACB) have been trending positive recently, Accern Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Pacific Biosciences of California earned a news impact score of 0.33 on Accern’s scale. Accern also gave news articles about the biotechnology company an impact score of 46.7941607057081 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Hot Performing Stocks To Invest In 2019: Midatech Pharma PLC(MTP)
Advisors’ Opinion:
- [By Logan Wallace]
News articles about Midatech Pharma (NASDAQ:MTP) have trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Midatech Pharma earned a coverage optimism score of 0.04 on Accern’s scale. Accern also gave press coverage about the company an impact score of 47.6134155747452 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
- [By Shane Hupp]
Media stories about Midatech Pharma (NASDAQ:MTP) have trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Midatech Pharma earned a news sentiment score of 0.05 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.0428548550507 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
- [By Money Morning Staff Reports]
But before we show you our pick, here are the top 10 penny stocks to watch this week…
Penny Stocks Current Share Price (as of Jan. 5) Jan. 2-5 Gain (as of Jan. 5)
My Size Inc. (Nasdaq: MYSZ) $1.66 152.28%
Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.47 89.52%
DelMar Pharmaceuticals Inc. (Nasdaq: DMPI) $1.675 58.02%
CAS Medical Systems Inc. (Nasdaq: CASM) $1.09 55.71%
China HGS Real Estate Inc. (Nasdaq: HGSH) $1.83 47.58%
Aethlon Medical Inc. (Nasdaq: AEMD) $1.56 43.12%
Midatech Pharma Plc. (Nasdaq: MTP) $1.23 43.01%
Comstock Holding Cos. Inc. (Nasdaq: CHCI) $1.87 36.5%
Cenveo Inc. (Nasdaq: CVO) $1.20 31.82%
EV Energy Partners LP (Nasdaq: EVEP) $0.6844 31.62%FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…